MUMBAI (Diya TV) A major shift is coming to Indias drug market that could change how millions access weight-loss medicine
Weight Loss Injections and Cholesterol Reduction Injections like Semaglutide and Tirzepatide have gained popularity due to their dual benefits of weight loss and metabolic improvement
After taking individual risk factors into account, the risk for non-live birth was 29.7% with medication continuation versus 27.1% with non-continuation, a difference that was not deemed statistically significant
This peptide does so by binding to specific receptors in the brain, which in turn triggers the release of growth hormone
Tracking these metrics every 2-4 weeks provides more meaningful progress assessment than daily scale weight, which fluctuates with hydration, bowel contents, and other transient factors
While not FDA-approved for these conditions, studies have shown that GLP-1 agonists may also have additional health benefits, including: Reducing blood pressure Lowering cholesterol levels Reducing heart disease risk Improving fatty liver disease Side Effects & Risks GLP-1 medications may cause side effects, especially when first taking it
